Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.398
+0.018 (0.76%)
Oct 29, 2026, 1:10 PM EDT - Market open

Acumen Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-103.96-121.34-102.33-52.37-42.86-100.61
Depreciation & Amortization
0.180.180.180.180.170
Asset Writedown & Restructuring Costs
---0.74--
Loss (Gain) From Sale of Investments
-0.14-0.87-5.11-3.130.490.16
Stock-Based Compensation
10.059.859.646.153.060.92
Other Operating Activities
0.611.75-0.241.51-81.27
Change in Accounts Payable
5.37-5.094.27-0.260.550.56
Change in Other Net Operating Assets
-0.07-0.037.384.133.43-0.26
Operating Cash Flow
-87.95-115.54-86.22-43.06-35.15-17.96
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.09-0.02-0.02-0.16-0.04
Sale of Property, Plant & Equipment
---0--
Investment in Securities
63.69134.0248.04-171.6539.35-104.08
Investing Cash Flow
63.69133.9348.03-171.6739.19-104.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---30--
Long-Term Debt Repaid
---0.74---
Net Debt Issued (Repaid)
-4.99--0.7430--
Issuance of Common Stock
35.640.047.94122.233.91169.19
Repurchase of Common Stock
-0.15-0.07-0.04---
Other Financing Activities
---0.23-0.48--
Financing Cash Flow
30.5-0.036.93151.753.91200.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
6.2418.36-31.26-62.987.9478.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-87.95-115.63-86.23-43.09-35.31-18
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.31-1.91-1.44-0.89-0.87-0.90
Levered Free Cash Flow
-52.43-75.11-52.29-28.24-20.94-16.35
Unlevered Free Cash Flow
-49.77-72.47-49.75-27.87-20.94-16.35

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.92.942.970.17--
Change in Working Capital
5.3-5.1211.653.873.990.3
SEC Filings: 10-K · 10-Q